Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes

Authors:

Abstract
No abstract available

This publication has 24 references indexed in Scilit: